|
|
滋阴和温阳方剂对帕金森病小鼠神经损伤及肠道炎症和肠微生态的影响
|
Abstract:
目的：探索滋阴和温阳方剂(六味地黄丸与肾气丸)对帕金森病小鼠神经损伤及肠道炎症和肠微生态的影响。方法：将小鼠随机分为对照组、MPTP处理组、补脾组、滋阴组、温阳组，用MPTP诱导的亚急性帕金森病小鼠模型，观察滋阴和温阳方剂对帕金森病小鼠纹状体多巴胺含量、运动能力、回肠和纹状体中的细胞炎性因子的表达、肠道微生态的影响作用。结果：滋阴和温阳方剂可明显促进帕金森病小鼠神经损伤的恢复,促进多巴胺的含量增加(p < 0.05)，并且温阳方剂较滋阴方剂效果更明显(p < 0.05)，增加纹状体中酪氨酸羟化酶基因的表达(p < 0.05)，且温阳方剂效果更明显(p < 0.001)，运动能力较MPTP组也有显著的恢复(p < 0.05)并且温阳方剂较滋阴方剂效果更明显(p < 0.05)；抑制纹状体中IL-1β基因的表达(p < 0.05)，且温阳方剂效果更明显(p < 0.05)，抑制回肠中IL-1β基因的表达(p < 0.0001)，并促进回肠中IL-22基因的表达(p < 0.05)；促进回肠中的粘膜屏障结构修复；在门、科、属水平上，各组肠道微生物中优势物种类似，但丰度有所不同，滋阴组chao指数显著升高(p < 0.05)，PCoA分析中各组肠道微生物的群落组成均存在显著的差异(R = 0.2942, p =0.003)。讨论：滋阴方与温阳方(六味地黄丸与肾气丸)可以改善帕金森病小鼠所产生的运动症状、肠道菌群失调、肠道炎症、肠粘膜屏障受损、DA能神经细胞损伤的情况，且温阳配方较滋阴配方效果稍强。
Objective: To explore the effects of Zi Yin and Wen Yang formulas (Liu Wei Di Huang Wan and Ren Qi Wan) on nerve injury and intestinal inflammation and intestinal microecology in mice with Parkinson’s disease. Methods: Mice were randomly divided into control group, MPTP-treated group, spleen tonic group, Zi yin group and Wen yang group with MPTP-induced subacute Parkinson’s disease mouse model to observe the effects of Zi Yin and Wen Yang formulas on striatal dopamine content, motility, expression of cellular inflammatory factors in ileum and striatum, and intestinal microecology in mice with Parkinson’s disease. Results: Zi Yin and Wen Yang formulas significantly promoted the recovery of nerve damage in Parkinson's disease mice, increased the content of dopamine (p < 0.05), and Wen Yang formulae were more effective than Zi Yin formulae (p < 0.05), increased the expression of tyrosine hydroxylase gene in the striatum (p < 0.05), and Wen Yang formulae were more effective (p < 0.001), and motor ability was also significantly restored compared with the MPTP group (p < 0.05). There was a significant recovery of motility (p < 0.05) and the effect of the Wen Yang formula was more pronounced than that of the Zi Yin formula (p < 0.05); inhibited the expression of IL-1β gene in the striatum (p < 0.05), and the effect of the Wen Yang formula was more pronounced (p < 0.05), inhibited the expression of IL-1β gene in the ileum (p < 0.0001), and promoted the expression of IL-22 gene in the ileum (p < 0.05); promoted the repair of mucosal barrier structure in ileum; at the level of phylum, family and genus, the dominant species were similar in each group of intestinal microorganisms, but the abundance was different, and the chao index was significantly higher in the Zi Yin group (p < 0.05), and there were significant differences in the community
| [1] | 左琦, 郑乾, 焦玲, 等. 特发性震颤发展为帕金森病研究进展[J]. 中国现代神经疾病杂志, 2022, 22(4): 237-242. |
| [2] | 何江, 刘春杰, 周灵羽, 等. 幽门螺杆菌感染对帕金森病影响的研究进展[J]. 西藏科技, 2022(4): 34-38. |
| [3] | Marogianni, C., Sokratous, M., Dardiotis, E., et al. (2020) Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease. International Journal of Molecular Sciences, 21, Article No. 8421.
https://doi.org/10.3390/ijms21228421 |
| [4] | Trist, B.G., Hare, D.J. and Double, K.L. (2019) Oxidative Stress in the Aging Substantia Nigra and the Etiology of Parkinson’s Disease. Aging Cell, 18, e13031. https://doi.org/10.1111/acel.13031 |
| [5] | Dorsey, E.R., Sherer, T., Okun, M.S., et al. (2018) The Emerging Evidence of the Parkinson Pandemic. Journal of Parkinson’s Disease, 8, S3-S8. https://doi.org/10.3233/JPD-181474 |
| [6] | Pessoa, R.R., Moro, A., Munhoz, R.P., et al. (2018) Apomorphine in the Treatment of Parkinson’s Disease: A Review. Arquivos de Neuro-Psiquiatria, 76, 840-848. https://doi.org/10.1590/0004-282x20180140 |
| [7] | Jiménez-Urbieta, H., Gago, B., De La Riva, P., et al. (2015) Dyskinesias and Impulse Control Disorders in Parkinson’s Disease: From Pathogenesis to Potential Therapeutic Approaches. Neuroscience and Biobehavioral Reviews, 56, 294-314. https://doi.org/10.1016/j.neubiorev.2015.07.010 |
| [8] | 米文静, 孙灵芝. 线粒体功能障碍与帕金森病的相关性及中医药对其干预作用研究进展[J]. 实用心脑肺血管病杂志, 2022, 30(6): 125-130. |
| [9] | 郭云霞, 杨明会. 中医药干预帕金森病实验研究进展[J]. 环球中医药, 2013, 6(10): 773-778. |
| [10] | 甘盼盼, 刘玲, 全毅红. 中药联合西医常规治疗帕金森病伴轻度认知功能障碍的临床有效性及安全性的Meta分析[J]. 广州中医药大学学报, 2022, 39(8): 1938-1946.
https://doi.org/10.13359/j.cnki.gzxbtcm.2022.08.038 |
| [11] | 万叶, 郭春燕, 李永民. 中药在帕金森病领域的研究进展[J]. 神经药理学报, 2017, 7(4): 36-42. |
| [12] | 林沛. 中医治疗帕金森病抑郁的研究进展[J]. 大众科技, 2022, 24(7): 106-108+91. |
| [13] | 徐展铄, 李雪蓉. 帕金森病的药物治疗进展[J]. 临床合理用药杂志, 2016, 9(25): 180-181.
https://doi.org/10.15887/j.cnki.13-1389/r.2016.25.114 |
| [14] | 叶承莉, 白群华, 苏咏梅, 等. 滋阴方与温阳方对鱼藤酮诱导PC12细胞损伤的保护作用[J]. 中医学报, 2018, 33(11): 2164-2171. https://doi.org/10.16368/j.issn.1674-8999.2018.11.511 |
| [15] | 刘欣, 刘忠于, 陈晖娟, 等. 肠道菌群与帕金森病相关性的研究进展[J]. 结直肠肛门外科, 2020, 26(4): 410-413.
https://doi.org/10.19668/j.cnki.issn1674-0491.2020.04.005 |
| [16] | 方家瑞, 李喆, 任邑昆, 等. 肠道菌群-肠脑轴在神经退行性疾病发生和防治中的作用[J]. 郑州大学学报(医学版), 2021, 56(3): 327-331. https://doi.org/10.13705/j.issn.1671-6825.2020.06.006 |
| [17] | 周佳文, 王正波. 基于肠脑轴传播α-突触核蛋白诱发帕金森病的研究进展[J]. 生物工程学报, 2022, 38(6): 2120-2127. https://doi.org/10.13345/j.cjb.210822 |
| [18] | Scheperjans, F., Aho, V., Pereira, P., et al. (2015) Gut Microbiota Are Related to Parkinson’s Disease and Clinical Phenotype. Movement Disorders: Official Journal of the Movement Disorder Society, 30, 350-358.
https://doi.org/10.1002/mds.26069 |
| [19] | Unger, M.M., Spiegel, J., Dillmann, K.-U., et al. (2016) Short Chain Fatty Acids and Gut Microbiota Differ between Patients with Parkinson’s Disease and Age-Matched Controls. Parkinsonism & Related Disorders, 32, 66-72.
https://doi.org/10.1016/j.parkreldis.2016.08.019 |
| [20] | Keshavarzian, A., Green, S.J., Engen, P.A., et al. (2015) Colonic Bacterial Composition in Parkinson’s Disease. Movement Disorders: Official Journal of the Movement Disorder Society, 30, 1351-1360.
https://doi.org/10.1002/mds.26307 |
| [21] | 段智璇, 田维毅. 中药对肠道菌群及肠黏膜屏障功能的影响[J]. 内蒙古医学杂志, 2016, 48(9): 1053-1057.
https://doi.org/10.16096/J.cnki.nmgyxzz.2016.48.09.010 |
| [22] | 殷琳, 夏文睿, 黄国鑫, 等. 中药-肠道菌群互作与宿主自身代谢免疫稳态相关性的研究进展[J]. 中草药, 2022, 53(8): 2526-2538. |
| [23] | 柯群华, 彭晶, 王胜义. 中药与肠道菌群及其代谢相关研究进展[J]. 中兽医医药杂志, 2022, 41(2): 35-40.
https://doi.org/10.13823/j.cnki.jtcvm.2022.02.007 |
| [24] | 王丝雨, 陆艳, 何玲, 等. 中药对肠黏膜免疫调节作用的研究进展[J]. 贵州中医药大学学报, 2021, 43(6): 70-73+87. https://doi.org/10.16588/j.cnki.issn2096-8426.2021.06.015 |
| [25] | 梁小瑞, 王丹阳, 乔彦杰, 等. 三味清热类中药水提物对肉仔鸡肠道菌群和黏膜屏障功能的影响[J]. 中国畜牧兽医, 2020, 47(7): 2043-2054.
https://doi.org/10.16431/j.cnki.1671-7236.2020.07.009 |
| [26] | 边甜甜, 司昕蕾, 牛江涛, 等. 脾气虚证与肠道菌群的相关性及健脾益气中药对肠道菌群的调节作用研究进展[J]. 中药药理与临床, 2022, 38(5): 212-217.
https://doi.org/10.13412/j.cnki.zyyl.20210924.002 |
| [27] | Xie, W., Gao, J., Jiang, R., et al. (2020) Twice Subacute MPTP Administrations Induced Time-Dependent Dopaminergic Neurodegeneration and Inflammation in Midbrain and Ileum, as Well as Gut Microbiota Disorders in PD Mice. Neurotoxicology, 76, 200-212. https://doi.org/10.1016/j.neuro.2019.11.009 |
| [28] | 曹凌晓, 董威, 李渊, 等. 帕金森病合并脑小血管病人脑组织病理学分析: 附一例报告并文献复习[J]. 中国现代神经疾病杂志2021, 21(4): 255-261. |
| [29] | 张杨, 蒋森, 刘娜, 等. 早期帕金森病患者步态特征定量分析[J]. 中国实用神经疾病杂志, 2021, 24(24): 2145-2151. |
| [30] | 王蓉, 欧阳敏, 张萍, 等. 帕金森病小鼠黑质纹状体小胶质细胞活化表达的炎性因子与多巴胺含量的关系[J]. 中国老年学杂志, 2014, 34(10): 2768-2770. |
| [31] | 邵方泽, 梁世倩, 秦鸿雁. 小胶质细胞在帕金森病中的作用及其研究进展[J]. 神经解剖学杂志, 2020, 36(5): 565-569. https://doi.org/10.16557/j.cnki.1000-7547.2020.05.015 |
| [32] | Morel, L., Domingues, O., Zimmer, J., et al. (2020) Revisiting the Role of Neurotrophic Factors in Inflammation. Cells, 9, Article No. 865. https://doi.org/10.3390/cells9040865 |
| [33] | 秦丽清, 吴林, 潘艺彬, 等. 基于肠道菌群探讨从脾胃论治帕金森病[J]. 辽宁中医药大学学报, 2022, 24(10): 98-102. https://doi.org/10.13194/j.issn.1673-842x.2022.10.020 |
| [34] | 张佳丽, 梁翌, 赵晓峰. 基于肠道菌群探讨脾胃为后天之本[J]. 中国中医药信息杂志, 2020, 27(10): 21-25.
https://doi.org/10.19879/j.cnki.1005-5304.201905247 |
| [35] | Yang, Y., Qiu, W.Q., Hao, Y.L., et al. (2015) The Efficacy of Traditional Chinese Medical Exercise for Parkinson’s Disease: A Systematic Review and Meta-Analysis. PLOS ONE, 10, e0122469.
https://doi.org/10.1371/journal.pone.0122469 |
| [36] | Nielsen, S.D., Pearson, N.M. and Seidler, K. (2021) The Link between the Gut Microbiota and Parkinson’s Disease: A Systematic Mechanism Review with Focus on α-Synuclein Transport. Brain Research, 1769, Article ID: 147609. |
| [37] | 路晓娟, 李会芳, 李东明, 等. 地黄饮子对肾虚证帕金森病小鼠的肠道菌群调节作用研究[J]. 时珍国医国药, 2021, 32(6): 1316-1320. |
| [38] | 常学辉, 张良芝, 黎民. 龟羚帕安丸对帕金森病大鼠神经干细胞移植后中脑黑质TH、GDNF、Ptx3表达的影响[J]. 中成药, 2018, 40(8): 1681-1686. |
| [39] | 贺燕. 外周血免疫相关细胞及细胞因子与帕金森病相关性分析[D]: [硕士学位论文]. 南昌: 南昌大学, 2021. |
| [40] | 王雅萍, 王晓丹, 叶佳. 首发抑郁症中青年患者肠道菌群与细胞因子的关联性研究[J]. 山西医药杂志, 2021, 50(8): 1303-1305. |
| [41] | Keir, M., Yi, T., Lu, T., et al. (2020) The Role of IL-22 in Intestinal Health and Disease. The Journal of Experimental Medicine, 217, e20192195. https://doi.org/10.1084/jem.20192195 |
| [42] | Yang, W., Yu, T., Huang, X., et al. (2020) Intestinal Microbiota-Derived Short-Chain Fatty Acids Regulation of Immune Cell IL-22 Production and Gut Immunity. Nature Communications, 11, Article No. 4457.
https://doi.org/10.1038/s41467-020-18262-6 |
| [43] | Kaminsky, L.W., Al-Sadi, R. and Ma, T.Y. (2021) IL-1β and the Intestinal Epithelial Tight Junction Barrier. Frontiers in Immunology, 12, Article ID: 767456. https://doi.org/10.3389/fimmu.2021.767456 |
| [44] | Li, H., Xiang, Y., Zhu, Z., et al. (2021) Rifaximin-Mediated Gut Microbiota Regulation Modulates the Function of Microglia and Protects against CUMS-Induced Depression-Like Behaviors in Adolescent Rat. Journal of Neuroinflammation, 18, Article No. 254. https://doi.org/10.1186/s12974-021-02303-y |
| [45] | Romano, S., Savva, G.M., Bedarf, J.R., et al. (2021) Meta-Analysis of the Parkinson’s Disease Gut Microbiome Suggests Alterations Linked to Intestinal Inflammation. NPJ Parkinson’s Disease, 7, Article No. 27.
https://doi.org/10.1038/s41531-021-00156-z |
